| Literature DB >> 34941822 |
Salem Djebala1, Julien Evrard2, Fabien Gregoire2, Calixte Bayrou1, Linde Gille1, Justine Eppe1, Hélène Casalta1, Vincent Frisée1, Nassim Moula3,4, Arnaud Sartelet1, Damien Thiry5, Philippe Bossaert1.
Abstract
The aim of this study was to identify the species and antimicrobial susceptibility of bacteria involved in parietal fibrinous peritonitis (PFP). We studied 156 peritoneal fluid samples from cows presenting PFP after caesarean section. Bacteria were cultured in selective media and their antimicrobial susceptibility was tested by disk diffusion assay. Bacteria were isolated in the majority (129/156; 83%) of samples. The majority (82/129; 63%) of positive samples contained one dominant species, while two or more species were cultured in 47/129 (36%) samples. Trueperella pyogenes (T. Pyogenes) (107 strains) was the most identified species, followed by Escherichia coli (E. coli) (38 strains), Proteus mirabilis (P. mirabilis) (6 strains), and Clostridium perfringens (C. perfringens) (6 strains). Several other species were sporadically identified. Antimicrobial susceptibility was tested in 59/185 strains, predominantly E. coli (38 strains) and P. mirabilis (6 strains). Antibiotic resistance, including resistance to molecules of critical importance, was commonly observed; strains were classified as weakly drug resistant (22/59; 37%), multidrug resistant (24/59; 41%), extensively drug resistant (12/59; 20%), or pan-drug resistant (1/59; 2%). In conclusion, extensive antibiotic resistance in the isolated germs might contribute to treatment failure. Ideally, antimicrobial therapy of PFP should be based upon bacterial culture and susceptibility testing.Entities:
Keywords: antimicrobial susceptibility; bacterial culture; caesarean section; parietal fibrinous peritonitis; peritoneal fluids
Year: 2021 PMID: 34941822 PMCID: PMC8707031 DOI: 10.3390/vetsci8120295
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
The results of aerobic and anaerobic culture performed on the PFP fluid samples.
| Aerobic/Facultative Anaerobic | Number of Positive Samples | Anaerobic | Number of Positive Samples |
|---|---|---|---|
|
| 107 |
| 6 |
|
| 38 |
| 3 |
|
| 6 | 1 | |
|
| 3 |
| 1 |
|
| 2 |
| 1 |
|
| 2 |
| 1 |
|
| 2 | / | / |
|
| 2 | / | / |
|
| 2 | / | / |
| 2 | / | / | |
|
| 1 | / | / |
| 1 | / | / | |
|
| 1 | / | / |
|
| 1 | / | / |
|
| 1 | / | / |
|
| 1 | / | / |
| contaminants | 9 | / | 1 |
| Total | 172 strains | Total | 13 strains |
The detailed antimicrobial susceptibility results observed in the bacteria identified in PFP.
| Bacteria Tested | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics | S | R | I | S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | I | S | R | S | R |
| amoxicillin-clavulanate | 15 | 10 | 13 | 5 | 1 | 3 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
| amoxicillin | 11 | 27 | 0 | 2 | 4 | / | / | 0 | 2 | / | / | 2 | 0 | / | / | / | / | / | / | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
| cefquinome | 30 | 8 | 0 | 6 | 0 | 3 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 |
| ceftiofur | 31 | 7 | 0 | 6 | 0 | 3 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
| colistin | 38 | 0 | 0 | 0 | 6 | / | / | 0 | 2 | / | / | 2 | 0 | / | / | / | / | / | / | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| enrofloxacin | 27 | 11 | 0 | 3 | 3 | 3 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| florfenicol | 20 | 16 | 2 | 5 | 1 | / | / | 1 | 1 | / | / | 2 | 0 | / | / | / | / | / | / | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
| gentamicin | 25 | 13 | 0 | 4 | 2 | 3 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 |
| kanamycin | 15 | 23 | 0 | 2 | 4 | / | / | 0 | 2 | / | / | 2 | 0 | / | / | / | / | / | / | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| marbofloxacin | 27 | 10 | 1 | 5 | 1 | 3 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| tetracycline | 12 | 26 | 0 | 0 | 6 | 1 | 2 | 0 | 2 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
| trimethoprim-sulfonamide | 15 | 23 | 0 | 2 | 4 | 3 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| cephalexin | / | / | / | / | / | 3 | 0 | / | / | 2 | 0 | / | / | 1 | 0 | 0 | 1 | 1 | 0 | / | / | / | / | / | / | / |
| cefoxitin | / | / | / | / | / | 3 | 0 | / | / | / | / | / | / | / | / | 0 | 1 | 1 | 0 | / | / | / | / | / | / | / |
| erythromycin | / | / | / | / | / | 1 | 2 | / | / | 2 | 0 | / | / | 0 | 1 | 1 | 0 | 1 | 0 | / | / | / | / | / | / | / |
| lincomycin | / | / | / | / | / | 1 | 2 | / | / | 2 | 0 | / | / | 1 | 0 | 1 | 0 | 1 | 0 | / | / | / | / | / | / | / |
| oxacillin | / | / | / | / | / | 3 | 0 | / | / | 2 | 0 | / | / | 0 | 1 | 0 | 1 | 1 | 0 | / | / | / | / | / | / | / |
| penicillin | / | / | / | / | / | 2 | 1 | / | / | 2 | 0 | / | / | 1 | 0 | 0 | 1 | 1 | 0 | / | / | / | / | / | / | / |
| spiramycin | / | / | / | / | / | 1 | 2 | / | / | 2 | 0 | / | / | 1 | 0 | 1 | 0 | 1 | 0 | / | / | / | / | / | / | / |
| tildipirosin | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | 1 | 0 | / | / | / | / | / | / | / |
| tulathromycin | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | 1 | 0 | / | / | / | / | / | / | / |
| gamitromycin | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | 1 | 0 | / | / | / | / | / | / | / |
| Species susceptibility | 266 | 174 | 16 | 32 | 40 | 36 | 9 | 6 | 18 | 27 | 1 | 24 | 0 | 12 | 2 | 5 | 10 | 15 | 0 | 3 | 7 | 2 | 5 | 7 | 8 | 4 |
| Total of tested strains | 456 | 72 | 45 | 24 | 28 | 24 | 14 | 15 | 15 | 12 | 12 | 12 | ||||||||||||||
E. coli: Escherichia coli; P. mirabilis: Proteus mirabilis; S. uberis: Streptococcus uberis; P. rettgeri: Providencia rettgeri; S. dysgalactiae: Streptococcus dysgalactiae; M. varigena: Mannheimia varigena; S. mitis: Streptococcus mitis; S. aureus: Staphylococcus aureus; A. rossii: Actinobacillus rossii; P. sp: Proteus sp; P. aeruginosa: Pseudomonas aeruginosa; S. typhimurium: Salmonella typhimurium. S: sensitive; I: intermediate; R: resistant.
Classification of the identified bacteria according to the degrees of resistance described by Magiorakos et al. (2012) [20].
| Bacteria Tested (Number of Tests) | Weakly Resistant: Resistant to Less than Three Tested Antimicrobial Classes | Multidrug Resistant: Resistant to Three or More Tested Antimicrobial Classes | Extensively Drug Resistant: Resistant to All Except One or Two Antimicrobial Classes | Pandrug Resistant: Resistant to All Tested Antimicrobials | |
|---|---|---|---|---|---|
| 12 (32%) | 18 (47%) | 8 (21%) | 0 | ||
| 1 (17%) | 3 (50%) | 2 (33%) | 0 | / | |
| 3 (100%) | 0 | 0 | 0 | / | |
| 0 | 1 (50%) | 0 | 1 (50%) | / | |
| 2 (100%) | 0 | 0 | 0 | / | |
| 2 (100%) | 0 | 0 | 0 | / | |
| 1 (100%) | 0 | 0 | 0 | / | |
| 0 | 1 (100%) | 0 | 0 | / | |
| 1 (100%) | 0 | 0 | 0 | / | |
| 0 | 0 | 1 (100%) | 0 | / | |
| 0 | 0 | 1 (100%) | 0 | / | |
| 0 | 1 (100%) | 0 | 0 | / | |
| Total | 22/59 (37%) | 24/59 (41%) | 12/59 (20%) | 1/59 (2%) |
E. coli: Escherichia coli; P. mirabilis: Proteus mirabilis; S. uberis: Streptococcus uberis; P. rettgeri: Providencia rettgeri; S. dysgalactiae: Streptococcus dysgalactiae; M. varigena: Mannheimia varigena; S. mitis: Streptococcus mitis; S. aureus: Staphylococcus aureus; A. rossii: Actinobacillus rossii; P. sp: Proteus sp; P. aeruginosa: Pseudomonas aeruginosa; S. typhimurium: Salmonella typhimurium.